ClinicalTrials.gg
RecruitingNCT05653440Updated Apr 13, 2026

Balancing Effortful and Errorless Learning in Naming Treatment for Aphasia

A Phase 2 interventional study of Accuracy-maximized condition and Effort-maximized condition in Aphasia and Stroke, sponsored by University of Pittsburgh. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-13.

Sponsored by University of Pittsburgh · Phase 2, Interventional, and Treatment

From the registry’s dates

  • Started Nov 2023; still recruiting 2 years 11 months later.
Phase
Phase 2
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Aphasia is a language disorder caused by stroke and other acquired brain injuries that affects over two million people in the United States and which interferes with life participation and quality of life. Anomia (i.e., word- finding difficulty) is a primary frustration for people with aphasia. Picture-based naming treatments for anomia are widely used in aphasia rehabilitation, but current treatment approaches do not address the long-term retention of naming abilities and do not focus on using these naming abilities in daily life. The current research aims to evaluate novel anomia treatment approaches to improve long-term retention and generalization to everyday life.

This study is one of two that are part of a larger grant. This record is for sub-study 1, which will adaptively balance effort and accuracy using speeded naming deadlines.

Read the detailed description

Study 1: Evaluate the benefits of balancing effortful and errorless learning via adaptive naming deadlines.

  • Study design: The investigators will enroll 30 people with aphasia in a randomized within-subjects crossover design comparing trained words in three retrieval conditions. Stimuli will be balanced across conditions using an established item-response theory algorithm developed by Dr. Hula (consultant). Participants will receive 8 sessions of treatment per condition (2x/ week for 4 weeks), with probes administered at baseline and 1 week, 3 months, and 6 months post-treatment. Condition treatment order will be randomly assigned and counter- balanced across participants. In total, Sub-study 1 includes typically 3-4 (but up to 6) assessment sessions, 24 treatment sessions, and 24 baseline and follow-up probe assessment sessions per participant over an approximately 10-month period, but up to 18 months. Data collection will take place at the Language Rehabilitation and Cognition Laboratory (LRCL) at the University of Pittsburgh, in participants' homes, or in private rooms in public spaces (e.g. libraries, community centers).
  • Participants: The investigators will recruit 30 male and female community-dwelling people with aphasia >6 months post- onset of aphasia due to left-hemisphere ischemic or hemorrhagic stroke. Aphasia diagnosis will be confirmed by Comprehensive Aphasia Test (CAT) performance and medical history. Investigators will exclude potential participants with a history of other acquired or progressive neurological disease, significant language comprehension impairments, unmanaged drug/alcohol dependence, and severe diagnosed mood or behavioral disorders that require specialized mental health interventions.
  • Assessment Procedures: Participants will be tested on a comprehensive initial battery of standardized assessments characterizing their aphasia severity and overall language profile, naming and discourse abilities, semantic processing, verbal short-term and working memory at baseline. Patient-reported measures of treatment motivation and pre-post changes in communication effectiveness will also be measured in response to each treatment condition. These tests will ensure that our participants well-characterized from a behavioral perspective, and measures will be used in secondary analyses and model development exploring predictors of treatment response.
  • Treatment description: Each training trial will consist of a fixation cross and picture presentation. A repetition cue (audio recording and written from of the target) will be provided to participants based on the deadlines described above. Participants will be instructed to name the picture and indicate when they have given their final answer via key press, with responses also timed and scored by clinician key press. In the errorless condition, they will be instructed to repeat the target, while in the other conditions they will be asked to try to name the picture independently before they hear the target. Once they have indicated that they have provided their final answer, they will receive accuracy feedback on the computer screen based on clinician scoring. To maximize the clinical relevance of this study, investigators will control total amount of treatment time (8 hours) between conditions, instead of controlling the total number of trials. This is because many more trials can be completed per hour in the errorless or balanced conditions compared to the effort-maximized condition, and investigators want study outcomes to practically inform clinicians on how best to spend limited treatment time.
02

Conditions studied

  • Aphasia
  • Stroke

Browse trials for

03

In context

Aphasia

338 studies on the registry are indexed under Aphasia; 95 are open to participants now.

This study's planned enrollment of 30 is close to the median of 30 across 298 interventional studies indexed under Aphasia.

Browse Aphasia studies →

Lead sponsor

University of Pittsburgh is the lead sponsor of 1,419 studies on the registry; 168 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 4 (44%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Existing diagnosis of chronic (>6 months) aphasia subsequent to left hemisphere ischemic or hemorrhagic stroke.
  • Impaired performance on 2/8 sections of the Comprehensive Aphasia Test.

Exclusion criteria

Exclusion Criteria:

  • History of other acquired or progressive neurological disease.
  • Significant language comprehension impairments
  • Unmanaged drug / alcohol dependence.
  • Severe diagnosed mood or behavioral disorders that require specialize mental health interventions.
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Effort-maximized, then accuracy-maximized, then effort-accuracy balanced

    All participants will receive all three naming treatment conditions in a randomized order - this is one possible ordering of those conditions.

    Behavioral: Accuracy-maximized condition · Behavioral: Effort-maximized condition · Behavioral: Effort-accuracy balanced condition

  • Experimental
    Effort-maximized, then effort-accuracy balanced, then accuracy-maximized

    All participants will receive all three naming treatment conditions in a randomized order - this is one possible ordering of those conditions.

    Behavioral: Accuracy-maximized condition · Behavioral: Effort-maximized condition · Behavioral: Effort-accuracy balanced condition

  • Experimental
    Accuracy-maximized, then effort-maximized, then effort-accuracy balanced

    All participants will receive all three naming treatment conditions in a randomized order - this is one possible ordering of those conditions.

    Behavioral: Accuracy-maximized condition · Behavioral: Effort-maximized condition · Behavioral: Effort-accuracy balanced condition

  • Experimental
    Accuracy-maximized, then effort-accuracy balanced, then effort-maximized

    All participants will receive all three naming treatment conditions in a randomized order - this is one possible ordering of those conditions.

    Behavioral: Accuracy-maximized condition · Behavioral: Effort-maximized condition · Behavioral: Effort-accuracy balanced condition

  • Experimental
    Effort-accuracy balanced, then effort-maximized, then accuracy maximized

    All participants will receive all three naming treatment conditions in a randomized order - this is one possible ordering of those conditions.

    Behavioral: Accuracy-maximized condition · Behavioral: Effort-maximized condition · Behavioral: Effort-accuracy balanced condition

  • Experimental
    Effort-accuracy balanced, then accuracy-maximized, then effort-maximized

    All participants will receive all three naming treatment conditions in a randomized order - this is one possible ordering of those conditions.

    Behavioral: Accuracy-maximized condition · Behavioral: Effort-maximized condition · Behavioral: Effort-accuracy balanced condition

Interventions

  • BehavioralAccuracy-maximized condition

    Naming treatment condition in which the target will be immediately provided for repetition at picture onset.

  • BehavioralEffort-maximized condition

    Naming treatment condition in which participants will have up to 10 seconds to respond before the target is provided for repetition.

  • BehavioralEffort-accuracy balanced condition

    Naming treatment condition in which naming deadlines will be determined based on the balanced effort-to-accuracy benefit ratio formalized above, calculated on clinician-provided accuracy and response time ratings. Deadlines will be recalculated session-by-session to adjust to participant-specific treatment gains over time.

06

What researchers measure

Primary outcomes

  1. Change in correct responses in Confrontation Naming of Treated Pictured Objects

    Confrontation naming accuracy of pictures targeted in each training condition will serve as a primary outcome. Individualized lists for each participant will be selected from a corpus of pictured objects. Performance will be evaluated twice at each timepoint. Change in performance from initial assessment to the 3-month follow-up timepoint on the treated items will serve as the primary outcome measure.

    Time frame: Initial assessment (pre-treatment), 3 months post-treatment

Secondary outcomes

  1. Change in correct responses in Confrontation Naming of Untreated Pictured Objects

    Confrontation naming accuracy of pictured untreated items (matched for linguistic difficulty to treated items in the primary outcome) for each training condition will serve as a secondary outcome control condition.

    Time frame: Initial assessment (pre-treatment), 3 months post-treatment

  2. Change in correct responses in Context Generalization of Treated and Untreated Pictured Objects

    Production of trained words on the context generalization complex scene description task for each training condition and corresponding untreated items will serve as a secondary outcome. Words from complex scenes and wordless picture books will be chosen for each participant. These words will consist of a subset of those selected for confrontation naming. Performance will be evaluated twice at each timepoint. Change in performance from initial assessment to the 3-month follow-up timepoint on the treated and untreated items will serve as a secondary outcome measure.

    Time frame: Initial assessment (pre-treatment), 3 months post-treatment

  3. Change in core lexicon analysis on the Aphasia Bank Discourse Protocol

    The Aphasia Bank Discourse Protocol is a brief, but thorough set of language tasks which will characterize participants' language at the discourse level. The protocol requires participants to generate discourse samples within the contexts of free speech, a picture description, a story narrative, and procedural discourse. Change in performance in core lexicon analysis on discourse samples from initial assessment to each post-treatment follow up timepoint will serve as a secondary outcome measure.

    Time frame: Initial assessment (pre-treatment), 3-months post-treatment

  4. Change in mean scores on the Aphasia Communication Outcome Measure Short-Form

    The Aphasia Communication Outcome Measure (ACOM) is a measure of patient-reported "communication functioning," defined as the ability to effectively convey and receive personally relevant messages in natural environments. Results are provided in T scores (sample mean of 50 with a standard deviations of 10), with higher scores indicating better communication functioning.

    Time frame: Initial assessment (pre-treatment), 1 week post-treatment.

  5. Score on the Adapted Intrinsic Motivation Inventory for Aphasia

    The adapted intrinsic motivation Inventory for aphasia is a brief instrument comprised of 7 subscales with a total of 45 items intended to characterize intrinsic motivation in people with aphasia. Each item is scored on a scale of 1-7. Higher total score is associated with higher intrinsic motivation.

    Time frame: 1 week post-treatment

07

Study locations

1 of 1 sites recruiting
  • Language Rehab and Cognition Lab, Department of Communication Sciences and Disorders, School of Health and Rehabilitation Sciences, University of Pittsburgh
    Pittsburgh, Pennsylvania 15260, United States
    Recruiting
    • William Evans, PhD · Contactwill.evans@pitt.edu · 412-383-6943
    • William Evans, PhD · Principal investigator
08

References and documents

Publications

  • van der Stelt CM, Cavanaugh R, Hula WD, Starns J, Kelly A, Goodman ML, Terhorst L, Hassany M, Brusilovsky P, Evans WS. Adaptive balancing of effort, accuracy and response speed in anomia treatment for post-stroke aphasia in community-based settings in the USA: a within-subjects randomised controlled trial protocol. BMJ Open. 2026 May 20;16(5):e116172. doi: 10.1136/bmjopen-2025-116172. PubMed 42161555 ↗

Individual participant data

Plan to share: Yes — The data sharing plan for this study includes the publication of discourse measures and other study data on Aphasia Bank (R01-DC008524), a large online repository of aphasia behavioral data that supports a great deal of productive aphasia corpora research. De-identified test scores, treatment, and probe data, and audio and/or video recordings of norming, probe, assessment, and treatment data will be shared to this repository for all study participants. Investigators will also make our experimental task files, protocols, and de-identified study data available through Open Science Framework (https://osf.io/) to encourage the replication, collaboration, and expansion of our work by other research groups. Last, investigators plan to publish a modeling and statistical package in open-access software, R, which will include functionality for calculating speed-accuracy tradeoff optimality using our multinomial ex-Gaussian response time model approach.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Analytic code

Time frame: Data will be shared at the time of study publication without planned end to access.

Access criteria: Anyone who wishes to access the data.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05653440
Collaborators
University of Massachusetts, Amherst, National Institute on Deafness and Other Communication Disorders (NIDCD)
Responsible party
William Evans (Assistant Professor, University of Pittsburgh) — Principal investigator
First posted
Dec 16, 2022
Start date
Nov 27, 2023
Primary completion
Jan 31, 2027 (estimated)
Completion
Jan 31, 2028 (estimated)
Last update
Apr 13, 2026

Study contacts

Alyssa Kelly, M.A., CCC-SLP
Contact
ank155@pitt.edu
412-648-3274
William Evans, PhD
principal investigator · University of Pittsburgh

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion